Impact of partial reimbursement on hepatitis B antiviral utilization and adherence

Table 2 Medication possession ratio and good adherence rate among patients with different insurance types before and after reimbursement

			Adherence (%)			Good adherence rate
		n	mean ± SD	New patients	Existing patients	Percent	New patients	Existing patients
Before	PMI	2825	83.4 ± 24.3a	82.3 ± 25.6d	84.5 ± 22.9d	70.6%	69.2	71.8
	PPO	3373	83.6 ± 24.2b	83.6 ± 24.8	83.6 ± 23.7	70.2%	70.5	69.9
After	PMI	4102	88.5 ± 19.7ac	87.1 ± 20.8e	90.2 ± 18.1e	79.2%g	77.0h	82.1h
	PPO	3619	85.2 ± 23.0bc	84.0 ± 24.1f	86.1 ± 22.1f	73.1%g	71.7	74.2

^aP < 0.01 among PMI before reimbursement vs after reimbursement;

^bP < 0.01 among PPO before reimbursement vs after reimbursement;

^cP < 0.01 between PMI and PPO after reimbursement;

^dP < 0.05 between new and existing PMI before reimbursement;

^eP < 0.01 between new and existing PMI after reimbursement;

^fP < 0.01 between new and existing PPO after reimbursement;

^gP < 0.01 between PMI and PPO after reimbursement;

^hP < 0.01 between new and existing PMI after reimbursement. PMI: Patients with medical insurance; PPO: Patients paid out-of-pocket.